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Abstract
Background: Tendons are traditionally thought to consist of tenocytes only, the resident cells of tendons;
however, a recent study has demonstrated that human and mouse tendons also contain stem cells, referred to as
tendon stem/progenitor cells (TSCs). However, the differential properties of TSCs and tenocytes remain largely
undefined. This study aims to characterize the properties of these tendon cells derived from rabbits.
Methods: TSCs and tenocytes were isolated from patellar and Achilles tendons of rabbits. The differentiation
potential and cell marker expression of the two types of cells were examined using histochemical,
immunohistochemical, and qRT-PCR analysis as well as in vivo implantation. In addition, morphology, colony
formation, and proliferation of TSCs and tenocytes were also compared.
Results: It was found that TSCs were able to differentiate into adipocytes, chondrocytes, and osteocytes in vitro,
and form tendon-like, cartilage-like, and bone-like tissues in vivo. In contrast, tenocytes had little such differentiation
potential. Moreover, TSCs expressed the stem cell markers Oct-4, SSEA-4, and nucleostemin, whereas tenocytes
expressed none of these markers. Morphologically, TSCs possessed smaller cell bodies and larger nuclei than
ordinary tenocytes and had cobblestone-like morphology in confluent culture whereas tenocytes were highly
elongated. TSCs also proliferated more quickly than tenocytes in culture. Additionally, TSCs from patellar tendons
formed more numerous and larger colonies and proliferated more rapidly than TSCs from Achilles tendons.
Conclusions: TSCs exhibit distinct properties compared to tenocytes, including differences in cell marker
expression, proliferative and differentiation potential, and cell morphology in culture. Future research should
investigate the mechanobiology of TSCs and explore the possibility of using TSCs to more effectively repair or
regenerate injured tendons.
Background
The function of tendons is to transmit muscular forces
to bone, permitting joint motion and subsequent body
movement. Therefore, tendons are constantly subjected
to large mechanical loads and, as a result, are prone to
acute injuries. For example, during sports activities,
acute partial tendon injuries are common [1]. Injured
tendons heal slowly and often result in the formation of
inferior scar tissue or fibrous adhesions, which increases
the risk of re-injury at the repair site. Tendons are also
susceptible to loading-induced tendinopathy, a broad
term describing tendon inflammation and degenerative
changes [2]. Despite its high prevalence, the pathogenic
mechanisms of tendinopathy are unclear and conse-
quently, current treatments are largely palliative. In fact,
the restoration of normal structure and function of
injured tendons represents one of the most challenging
areas in orthopaedic medicine.
In recent years, a tissue engineering approach has
been sought to improve the structure and function of
injured tendons using stem cell therapy [3]. A common
source of stem cells used in tissue engineered repair of
injured tissues is bone marrow mesenchymal stem cells
(BMSCs). BMSCs are multipotent cells that can differ-
entiate into several cell types [4], including chondrocytes
and osteoblasts. BMSC therapy therefore offers a pro-
mising treatment option for damaged cartilage and bone
[5]. BMSCs have also been used in the repair of injured
tendons, but in many cases ectopic bone was formed
within tendons in a rabbit tendon injury model [6].
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and autologous tenocytes, have also been used to treat
injured tendons, meeting with varying degrees of success
[7,8]. Therefore, the development of new effective cell
therapies for the restoration of normal tendon structure
and function is highly desirable, but progress has been
hindered by a lack of characterization of tendon cells.
Recently, remarkable progress has been made with the
identification of human and mouse tendon stem/pro-
genitor cells (TSCs) [9]. TSCs are characterized by their
multidifferentiation potential, including differentiation
into adipocytes, chondrocytes, and osteocytes. However,
de Mos et al. showed that tendon-derived fibroblasts
(TDFs) from adolescent non-degenerative human ham-
string tendons are able to differentiate into adipocytes,
chondrocytes, and osteocytes [10], suggesting that ten-
don fibroblasts or tenocytes may have trans-differentia-
tion potential. As tendons contain predominantly
tenocytes, in addition to newly identified TSCs, these
previous studies raise the question of whether TSCs and
tenocytes share common properties in their phenotypes
or whether they are completely different types of cells
with different characteristics. We hypothesized that
TSCs differ from tenocytes in differentiation potential,
cell marker expression, morphology, and proliferative
potential. To test this hypothesis, we used young rabbits
to isolate TSCs and tenocytes from patellar and Achilles
tendons for characterizing their cellular properties. No
studies to date have reported TSCs in rabbits, which are
often used as an animal model for the study of tendon
healing and biomechanics due to their relatively large
size and low cost for in vivo experiments [11,12].
Methods
Isolation of TSCs and tenocytes
The cell isolation method was based on a previous study
[9]. Fifteen female New Zealand white rabbits (8-10
week-old, 3.0 - 4.0 kg) were used in all experiments.
The protocol for use of the rabbits was approved by the
IACUC of the University of Pittsburgh. All rabbits were
fully sedated using intra-muscular Ketamine (10 mg/kg)
and Xylazine (3 mg/kg) injection and were then sacri-
ficed. After sacrifice, rabbit patellar and Achilles tendons
were dissected. The middle portions of tendons, which
were utilized for cell culture, were obtained by cutting
the tendon samples 5 mm from the tendon-bone inser-
tion and tendon-muscle junction. The tendon sheath
and surrounding paratenon were removed, and the mid-
dle tendon portion tissues were then weighed and
minced into small pieces (1 mm × 1 mm × 1 mm).
Each 100 mg tissue sample was digested with 3 mg col-
lagenase type I (Worthington Biochemical Corporation,
Lakewood, NJ) and 4 mg dispase (StemCell technologies
Inc., Vancouver, BC, Canada) in 1 ml phosphate-
buffered saline (PBS) at 37°C for 1 hr. The suspensions
were centrifuged at 1,500 g for 15 min, and the superna-
tant was discarded. The remaining cell pellet was re-sus-
pended in growth medium consisting of Dulbecco’s
modified Eagle’s medium (DMEM; Lonza, Walkersville,
MD) supplemented with 20% fetal bovine serum (FBS;
Atlanta Biologicals, Lawrenceville, GA), 100 μM2 - m e r -
captoethanol (Sigma-Aldrich, http://www.sigmaaldrich.
com), 100 U/ml penicillin and 100 μg/ml streptomycin
(Atlanta Biologicals, Lawrenceville, GA). A single-cell
suspension was obtained by diluting the suspension to 1
cell/μl and then cultured in either a 96 well plate or
T25 flasks at 37°C with 5% CO2. After 8-10 days in cul-
ture, patellar TSCs (PTSCs) and Achilles TSCs (ATSCs)
formed colonies on the culture surface of the plate or
flask. The cell colonies were stained with methyl violet.
Colony numbers and total cell number of all colonies
were counted using a hemocytometer.
In separate cultures, indivi d u a lc e l lc o l o n i e sw e r e
detached by local application of trypsin under micro-
scopic visualization. The detached cell colonies were
collected using a micropipette and transferred to indivi-
dual T25 flasks for further culture. After removal of cell
colonies, tenocytes, which were spread around, remained
in culture plates. These cells, which were elongated in
shape, were cultured further with the addition of regular
growth medium (DMEM plus 10% FBS).
TSC and tenocyte proliferation was assessed with
population doubling time (PDT), defined as the total
culture time divided by the number of generations. The
number of generations was expressed as log2Nc/N0,
where N0 is the population of the cells seeded initially,
and Nc is the population at confluence.
In vitro differentiation experiment
The multi-differentiation potential of the TSCs was
tested in vitro for adipogenesis, chondrogenesis, and
osteogenesis. TSCs at passage 1 were seeded in a 6-well
plate at a density of 2.4 × 10
5 cells/well in basic growth
medium (10% heat inactivated FBS, 100 U/ml penicillin
and 100 μg/ml streptomycin in DMEM-low glucose). To
test adipogenic potential, TSCs were cultured in adipo-
genic induction medium (Millipore, Cat. # SCR026) con-
sisting of basic growth medium supplemented with 1
μM dexamethasone, 10 μg/ml insulin, 100 μMi n d o -
methacin, and 0.5 mM isobutylmethylxanthine (IBMX).
As a test of chondrogenic potential, TSCs were cultured
in basic growth medium plus 40 μg/ml proline, 39 ng/
ml dexamethasone, 10 ng/ml TGF-b 3, 50 μg/ml ascor-
bate 2-phosphate, 100 μg/ml sodium pyruvate, and 50
mg/ml insulin-transferrin-selenious acid mix (ITS) from
BD Bioscience (Bedford, MA). Finally, osteogenic poten-
tial was tested by culturing TSCs in osteogenic induc-
tion medium (Millipore Cat. # SCR028) consisting of
basic growth medium augmented with 0.1 μM
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mM glycerol 2-phosphate. TSCs cultured in basic
growth medium were used for control cells. To assay
adipogenesis, chondrogenesis, and osteogenesis of TSCs,
Oil Red O, Safranin O, and Alizarin Red S assays (see
below), respectively, were used.
In addition to assessing differentiation potential of
TSCs, the possible trans-differentiation potential of
patellar tenocytes (PTs) and Achilles tenocytes (ATs)
was also tested by the same assays used for testing
TSCs. PTs and ATs were grown in the same culture
conditions as TSCs.
Oil red O assay
After culturing in adipogenic medium for 21 days, differ-
entiated adipocytes were detected by an Oil Red O assay.
In short, the medium was removed from the cell culture
plates, and the cells were washed with PBS 3 times each
for 5 min. The cells were then fixed using 4% paraformal-
dehyde for 40 min at room temperature. Subsequently,
the cells were washed with PBS 3 times each for 5 min,
then water 2 times each for 5 min, and finally incubated
with a 0.36% Oil Red O solution (Millipore, Cat. # 90358)
for 50 min, followed by washing 3 times with water.
Stained samples were examined on an inverted micro-
scope (Nikon eclipse, TE2000-U); images were obtained
by a CCD (charge-coupled device) camera on the micro-
scope and analyzed by SPOT™ imaging software (Diag-
nostic Instruments, Inc., Sterling Heights, MI). Stained
lipid droplets of the adipocytes appeared red.
Safranin O assay
Chondrogenesis was evaluated by Safranin O assay. Cells
cultured with chondrogenic differentiation medium for
21 days were fixed in ice cold ethanol for 1 hr, rinsed
with distilled water 2 times each for 5 min, and stained
at room temperature for 30 min with Safranin O solu-
tion (Sigma, St. Louis; Cat. # HT904). The cells were
rinsed 5 times with distilled water. The stained cells
were examined with an inverted microscope (Nikon
eclipse, TE2000-U), and images were taken with a CCD
camera, followed by image analysis with SPOT™ imaging
software. The stained glycosaminoglycans (GAG)-rich
matrix produced by chondrocytes appeared red.
Alizarin red S assay
The osteogenesis of TSCs was assessed by Alizarin Red
S assay. Cells cultured in osteogenic differentiation med-
ium for 21 days were fixed in chilled 70% ethanol for 1
hr, rinsed with distilled water twice each for 5 min, and
stained with Alizarin Red S (Millipore, Cat. # 2003999)
at room temperature for 30 min. The stained cells were
examined on an inverted microscope as described
above, with images being taken by a CCD camera and
analyzed by SPOT™ imaging software. The stained
osteocytes that contain mineral deposits appeared
orange-red.
Quantitative real-time RT-PCR (qRT-PCR) for gene analysis
The specific gene expression of differentiated TSCs was
determined using qRT-PCR. Total RNA was extracted
using an RNeasy Mini Kit with an on-column DNase I
digest (Qiagen, http://www.qiagen.com). First-strand
cDNA was synthesized in a 20 μl reaction from 1 μg
total RNA by reverse transcription with SuperScript II
(Invitrogen, http://www.invitrogen.com). The conditions
for the cDNA synthesis were: 65°C for 5 min and cool-
ing 1 min at 4°C, then 42°C for 50 min, 72°C for 15
min. The qRT-PCR was carried out using QIAGEN
QuantiTect SYBR Green PCR Kit (Qiagen) [13]. In a 50
μl PCR reaction mixture, 2 μl cDNA (total 100 ng RNA)
were amplified in a Chromo 4 Detector (MJ Research).
Rabbit-specific primers were used for collagen type I,
collagen type II, peroxisome proliferators-activated
receptor g (PPARg), Sox9, and Runx2. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as an
internal control. The forward and reverse primer
sequences and the resultant products were designed
according to published methods [14,15] and are listed in
Table 1. All primers were synthesized by Invitrogen.
After an initial denaturation for 10 min at 95°C, PCR
was performed for 30 cycles for GAPDH, collagen type I
and II, and 40 cycles for PPARg. Each cycle consisted of
denaturation for 50 seconds at 95°C, followed by anneal-
ing for 50 seconds at 58°C for GAPDH, and collagen I
a n dI I ,b u ta t5 6 ° Cf o rS o x 9 ,R u n x 2 ,a n dP P A R g.A t
least three independent experiments were performed to
obtain relative expression levels of each gene.
In vivo differentiation experiment
TSCs (5 × 10
5) were mixed with 150 μlM a t r i g e l( B D
Biosciences) in a 24-well tissue culture plate at 4°C.
After incubation for 30 min in medium (DMEM with
10% FBS and 1% penicillin/streptomycin), the gel-cells
were cultured at 37°C with 5% CO2 for another 30 min.
Human skin fibroblasts were treated in the same way as
the rabbit TSCs and used as a control. The gel-cells
were injected subcutaneously in the paraspinal region
bilaterally in six 10-week-old female nude rats (Charles
River Laboratories, Wilmington, MA). Tissue samples
were harvested at 8 weeks and placed in pre-labeled
base molds filled with frozen section medium (Neg 50;
Richard-Allan Scientific; Kalamazoo, MI). The base
mold with tissue samples was quickly immersed in
liquid nitrogen cold 2-methylbutane and allowed to soli-
dify completely. The tissue blocks were then placed on
dry ice and subsequently stored in the -80°C freezer
until being sectioned for histological analysis.
Histochemical and immunohistochemical analysis of
tissue sections
The tissue block was cut into 10 μm thick sections, and
they were then placed on glass slides and allowed to dry
overnight at room temperature. The sections were
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dehyde for 30 min, and washed with PBS three more
times. The sections were histochemically stained with
H&E, Alcian blue, and Alizarin Red S (all reagents were
from Sigma). For immunohistochemical staining, the
sections were coated with 5% goat serum and incubated
for 30 min at room temperature in a humid chamber.
The serum was carefully removed by aspiration and rab-
bit anti-collagen type I antibody (1:200; Rockland, Cat.
No. 600-401-103) was applied to the sections, which
were then incubated at room temperature for 2 hrs.
They were washed three times with PBS, reacted with
Cy3-conjugated donkey anti-rabbit IgG (1:500; Rockland,
Cat. No. 611-704-127) at room temperature for 1 hr,
again washed three times with PBS, and reacted with
Hoechst fluorochrome 33342 (1:1000; Sigma, Cat. No.
H33342) at room temperature for 5 min. Finally, the
sections were washed with running cold water for 5
min, followed by a distilled water rinse. The control
samples received the same treatments, except that pri-
mary antibodies were replaced with PBS.
Immunohistochemical analysis of cell markers
Using immunocytochemistry, we examined the following
stem cell markers: octamer-binding transcription factor 4
(Oct-4), stage-specific embryonic antigen-4 (SSEA-4), and
nucleostemin. The TSCs were fixed with 4% paraformal-
dehyde in phosphate-buffered saline for 30 min at room
temperature, blocked with 10% mouse serum for 1 hr at
room temperature, and reacted with mouse anti-human
Oct-4 (1:250; Millipore, Cat. No. MAB4401) or SSEA-4
antibody (1:500; ZYMED Laboratories, Invitrogen Immu-
nodetection, Cat. No. 41-4000) for 1 hr at room tempera-
ture. After washing the cells with PBS, Cy3-conjugated
goat anti-mouse secondary antibody (1:1000; Invitrogen
Molecular Probes, Cat. No. A10521) was applied for 30
min at room temperature for Oct-4 or FITC-conjugated
goat anti-mouse IgG (1:1000; BD Pharmingen, Cat. No.
554001) was applied for 30 min at room temperature for
SSEA-4. A similar protocol was adopted to perform
immuno-staining of nucleostemin on rabbit TSCs. The
staining protocol used goat anti-human nucleostemin anti-
body (1:300; Neuromics, Cat. No. GT15050) and Cy3-con-
jugated donkey anti-goat IgG secondary antibody (1:1000;
Millipore, Cat. No. AP180C). The cells were also counter-
stained with H33342 staining (Sigma). The stained cells
were examined using fluorescence microscopy. Human
skin fibroblasts (ATCC, #CRL-2703) were used as a nega-
tive control, while human patellar tendon stem cells, iso-
lated according to the protocol by a previous study [9],
were used as a positive control; both cell types received
the same treatments as rabbit TSCs.
Statistical Analysis
Data are presented as mean ± SD. At least three repli-
cates for each experimental condition were performed,
and the presented results were representative of these
replicates. One-way analysis of variance (ANOVA), fol-
lowed by Fisher’s predicted least-square difference
(PLSD) for multiple comparisons, or two tailed student
t-test wherever applicable, was used for statistical analy-
sis. Differences between two groups were considered
significant when the p-value was less than 0.05.
Results
Colony formation of TSCs
During the initial 2 days in culture, individual PTSCs
and ATSCs were present in culture plates. These cells
attached to the plate and remained quiescent for 3-5
d a y s .T h ef i r s tc o l o n yw a sn o t e dt of o r mf r o ms i n g l e
cells at 3 days. Numerous colonies were then formed at
10 days, and it is evident that PTSCs formed more and
l a r g e rc o l o n i e st h a nA T S C s( F i g u r e1 A ,B ,C ,D ) .T h e
size and density of these colonies, however, were hetero-
geneous (Figure 1A, B), indicating unequal rates of cell
proliferation among colonies.
Table 1 Primers for qRT-PCT analysis
Gene Size (bp) Primers Type Tm Gene Bank # Ref.
Collagen I 81 5’-CTG ACT GGA AGA GCG GAG AGT AC-3’ Forward 63°C AY633663 [14]
5’-CCA TGT CGC AGA AGA CCT TGA-3’ Reverse
Collagen II 84 5’-TGG GTG TTC TAT TTA TTT ATT GTC TTC CT-3’ Forward 63°C S83370 [14]
5’-GCG TTG GAC TCA CAC CAG TTA GT-3’ Reverse
Sox9 79 5’-AGT ACC CGC ACC TGC ACA AC-3’ Forward 59°C AY598935 [14]
5’-CGC TTC TCG CTC TCG TTC AG-3’ Reverse
Runx2 70 5’-TGA TGA CAC TGC CAC CTC TGA-3’ Forward 58°C AY598934 [14]
5’-GCA CCT GCC TGG CTC TTC T-3’ Reverse
GAPDH 107 5’-ACT TTG TGA AGC TCA TTT CCT GGT A-3’ Forward 63°C L23961 [14]
5’-GTG GTT TGA GGG CTC TTA CTC CTT-3’ Reverse
PPARg 200 5’-TGG GGA TGT CTC ATA ATG CCA-3’ Forward 59°C AF013266 [15]
5’-TTC CTG TCA AGA TCG CCC TCG-3’ Reverse
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colonies at a frequency of 42.1 ± 8.1 colonies and 48.3 ±
7.6 colonies per 10
5 viable cells, respectively. Further-
more, 50.3% of PTSC colonies consisted of 50,000 cells
or more, while only 23.2% of ATSC colonies had com-
parable populations (Figure 1E).
Cell multi-differentiation potential
We next examined whether TSCs were capable of differ-
entiating into various cell lineages, a characteristic of
stem cells. The potential of both PTSCs and ATSCs to
undergo adipogenesis, chondrogenesis and osteogenesis
was tested. When cells were cultured in adipogenic dif-
ferentiation medium, cytoplasmic lipid vesicles, an indi-
cator of adipocyte differentiation, first appeared at 7
days and the amounts of lipid production continued to
increase over culture time. After 21 days, numerous
lipid droplets were detected on differentiated PTSCs
and ATSCs (Figure 2A, E); however, a few lipid droplets
were present in the control cells, which were cultured in
basic growth medium without adipogenic supplements
(data not shown). Approximately 75% of PTSCs were
tested positive for lipid vesicles by Oil red O staining
(Figure 2A), whereas about 30% of ATSCs were positive
(Figure 2E).
When cultured in chondrogenic differentiation med-
ium, PTSCs spontaneously formed large aggregates in
culture at 13 days. Single aggregates were formed from
an entire monolayer, which rolled up from the edge of
the culture dish and contracted to form an irregularly
shaped mass. At 15 days, these initially loose aggregates
became firmer in texture and more spherical in shape.
This process also occurred 3 days earlier in ATSCs. Car-
tilage-like pellets were found in PTSCs (Figure 2C) and
ATSCs (Figure 2G) that had undergone chondrogenesis.
After culturing in chondrogenic medium for 21 days,
PTSCs and ATSCs were stained positive for GAG-rich
matrix with Safranin O assay (Figure 2B, F), whereas
control cells without exposure to the chondrogenic
medium were stained negative (data not shown).
Also, when PTSCs were cultured in osteogenic med-
ium for 21 days, calcium deposits were visible and
stained by Alizarin Red S assay (Figure 2D), whereas cal-
cium deposits were rarely found in control cells without
exposure to osteogenic medium (data not shown). Simi-
larly, calcium deposits in ATSCs were found in osteo-
genic conditions only (Figure 2H).
We also examined the possible trans-differentiation of
tenocytes. It was found that less than 5% of patellar
Figure 1 The colony formation of rabbit tendon stem cells (TSCs). A, B. Total PTSC and ATSC colonies stained with Methyl violet at 10 days.
C, D. Expanding colonies of PTSCs and ATSCs at 10 days, respectively. It is seen that more numerous and larger cell colonies were formed by
PTSCs compared to ATSCs. E. Quantitative analysis of colonies formed by PTSCs and ATSCs. Colony number of PTSCs was significantly different
from that of ATSCs (* p < 0.05). (Bars: 200 μm).
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stained positive for lipid drops, when both PTs and ATs
were cultured in adipogenesis medium and exposed to
the same conditions as TSCs (Figure 2I, M). Similarly,
cartilage-like pellets were not found and GAG-contain-
ing matrix was not detected by the staining of PTs or
A T s( F i g u r e2 J ,K ,N ,O ) .F i n a l l y ,f e wc a l c i u md e p o s i t s
were detected after staining in PTs and ATs treated
with the same conditions as TSCs (Figure 2L, P).
Specific marker gene expression
To confirm that TSCs derived from rabbit patellar and
Achilles tendons were differentiated into a specific line-
age, qRT-PCR was used to identify specific gene mar-
kers. Adipogenesis requires the sequential action of
PPARg [16]. Indeed, PTSCs cultured in adipogenic med-
ium for 21 days were found to exhibit significantly
higher levels of PPARg expression compared to control
PTSCs (Figure 3A, columns 1 and 2). Similarly, when
cultured in adipogenic medium, ATSCs also significantly
up-regulated expression of PPARg gene compared to
control cells (Figure 3B, columns 1 and 2).
To confirm that TSCs were able to differentiate into
chondrocytes, PTSCs and ATSCs were cultured in
chondrogenic medium and found to significantly
increase expression of the collagen type II gene (Figure
3 A ,B ,c o l u m n s3a n d4 ) .F u r t h e r m o r e ,s i g n i f i c a n t l y
higher levels of Sox9, a chondrogenic transcription fac-
tor, were expressed in PTSCs and ATSCs than in con-
trol cells (Figure 3A, B, columns 5 and 6).
Finally, to confirm the differentiation of TSCs into
osteocytes in osteogenic medium, induction of Runx2,
an osteoblast specific gene, was examined by qRT-PCR.
Both PTSCs and ATSCs in osteogenic medium
expressed significantly higher levels of Runx2 compared
to the same cells in control medium (Figure 3A, B, col-
umns 7 and 8).
Multi-differentiation potential of TSCs in vivo
After TSCs were subcutaneously transplanted into nude
mice, tendon-like, fibrocartilage-like, and bone-like tis-
sues were formed at 8 weeks after imlantation (Figure
4A, B, C). However, implantation of control fibroblasts
did not lead to formation of any of these tissues (data
not shown).
Morphology of TSCs and tenocytes in long term culture
Both PTSCs and ATSCs maintained a cobblestone shape
after being cultured for at least 63 days and more than
10 passages (Figure 5A, B), whereas tenocytes derived
from both patellar and Achilles tendons were highly
Figure 2 The testing of multi-differentiation potential of TSCs and tenocytes in vitro. A. Adipogenesis of PTSCs (arrows point to lipid
droplets). B. Chondrogenesis of PTSCs. C. Cartilage-like pellet (arrow) formed from PTSCs. D. Osteogenesis of PTSCs (An arrow points to a
clustered calcium droplet). Similar multi-differentiation potential is shown for ATSCs (E-H). Patellar tenocytes (PTs) and Achilles tenocytes (ATs)
were not found to exhibit such a multi-differentiation potential (I-P, also see text for additional descriptions of experimental results).
(Magnification of microscopy: 10×).
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s h a p es u g g e s t st h a tT S C s( P T S C sa n dA T S C s )a r ed i f -
ferent type of cells from tenocytes.
Cell marker expression
Immunocytochemical staining of these cells showed that
both PTSCs and ATSCs in culture for more than three
months at passages 10-13 expressed Oct-4 (Figure 6A,
B), SSEA-4 (Figure 6D, E), and nucleostemin (Figure
6G, H). However, tenocytes exhibited an absence or
very low levels of staining for these cell markers (Figure
6C, F, I), further confirming that TSCs and tenocytes
are two different types of tendon cells.
Proliferative potential of TSCs and tenocytes
T h eP D T sf o rP T S C sa n dP T sa tp a s s a g e2w e r e3 9 . 9±
5.5 hrs and 79.8 ± 7.3 hrs, respectively. In contrast, the
PDTs for ATSCs and ATs were 103.8 ± 6.8 hrs and
143.8 ± 7.0 hrs, respectively. The results indicate that
PTSCs and ATSCs proliferated faster than their coun-
terparts (i.e. PTs and ATs), and that PTSCs proliferated
faster than ATSCs (Figure 7). However, for PTSCs and
ATSCs at later passages (> 12), the PDTs were increased
to 187 ± 20.2 hr and 236 ± 40.1 hr, respectively, indicat-
ing that these cells were in a senescent state. Tenocytes
essentially did not grow at such high passages.
Discussion
This study aimed to determine whether TSCs and teno-
cytes, the two types of cells in tendons, share common
properties in their phenotypes. Towards this aim, TSCs
and tenocytes were isolated from rabbit patellar and
Achilles tendons, and their differentiation potential, cell
marker expression, morphology, and proliferative poten-
tial were examined. We found that TSCs were able to
differentiate into specific lineages of cells (adipocytes,
chondrocytes, and osteocytes), which was verified by
detection of specific marker gene expression. The multi-
differentiation potential of TSCs was further confirmed
by an in vivo experiment, which demonstrated that
Figure 3 The qRT-PCR analysis of expression of marker genes. Rabbit PTSCs and ATSCs were differentiated into adipocytes (PPARg),
chondrocytes (collagen II and Sox9), and osteocytes (Runx2) using their respective differentiation induction media. Compared to non-
differentiated, control cells (black columns) that were grown in regular growth medium, all these genes were significantly upregulated for both
PTSCs (A) and ATSCs (B), albeit at different levels (* p < 0.05). Note that for real time RT-PCR analysis, the gene expression levels were
normalized to GAPDH, obtained from at least three independent experiments and presented as 2
(-ΔCT).
Figure 4 The testing of multi-differentiation of rabbit TSCs in vivo. A. Formation of tendon-like tissue (TT) revealed by H&E staining and
immunohistochemical staining for collagen type I. The collagen fibers are parallel to each other (double arrow), indicative of formation of
tendon-like tissue (inset: collagen type I staining). B. Formation of fibrocartilage-like tissue (FT) (Alcian blue staining); and C. formation of bone-
like tissue (BT) (Alizarin Red S staining). (Bars: 50 μm).
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of tendon-like, fibrocartilage-like, and bone-like tissues.
We also showed that TSCs expressed Oct-4, SSEA-4,
and nucleostemin, which are known stem cell markers.
In contrast, tenocytes from both the patellar and
Achilles tendons essentially lacked trans-differentiation
potential; moreover, tenocytes did not express Oct-4,
SSEA-4, or nucleostemin. Morphologically, TSCs in
culture differ from tenocytes in that the former exhib-
ited a cobble-stone shape whereas the latter spread out
and were highly elongated, a characteristic shape of
fibroblasts in confluent conditions. Finally, TSCs prolif-
erated significantly faster than tenocytes in culture.
The finding that TSCs, but not tenocytes, were cap-
able of differentiating into non-tenocyte lineages of cells
suggests that TSCs may play a key role in tendinopathy.
Figure 5 The morphology of TSCs and tenocytes in culture. A, B. PTSCs and ATSCs at passage 10 were in culture for at least 63 days,
respectively. These cells were cobblestone-like in a confluent culture. C. Morphology of tenocytes from the same rabbit patellar tendons; similar
morphology was observed in tenocytes from the Achilles tendons (not shown). These tenocytes were highly elongated in a confluent culture.
(Bar: 50 μm).
Figure 6 The testing of stem cell marker expression. A, B. PTSCs and ATSCs at passages 10 expressed Oct-4, respectively. C.N oO c t - 4
staining was detected on tenocytes. D, E. PTSCs and ATSCs expressed SSEA-4. F. Tenocytes were negative for SSEA-4 staining. G, H. PTSCs and
ATSCs expressed nucleostemin. Insets show enlarged view of expressed nucleostemin in pink (arrows). I. Nucleostemin expression was not
detected on tenocytes. (bar: 50 μm).
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Page 8 of 11While the pathogenesis of tendinopathy is still not clear,
previous studies have identified typical histological fea-
tures including accumulation of lipid cells, glycosamino-
glycan accumulation, and tissue calcification, either
alone or in combination [17]. Therefore, by virtue of
their ability to differentiate into adipocytes, chondro-
cytes, and osteocytes, TSCs could be responsible for the
production of abnormal matrix components (e.g. fatty
degeneration, glycosaminoglycan accumulation, and cal-
cifications) seen in tendinopathic tendons. This is an
intriguing hypothesis that should be tested in future stu-
dies. In addition to TSCs, however, tenocytes may well
be involved in the development of tendinopathy through
production of inflammatory mediators [18-20] and tis-
sue degradative enzymes (MMPs)[21].
A few comments are in order regarding the stem cell
markers identified on TSCs but not on tenocytes in this
study. Oct-4 is a transcription factor that is typically
expressed in embryonic stem cells during development
and is essential for establishing and maintaining undif-
ferentiated pluripotent stem cells [22]. Like previous stu-
dies that showed Oct-4 expression in human and mouse
BMSCs [23-25], we also found that TSCs expressed
Oct-4, encouraging future examination of whether the
multi-potency of TSCs demonstrated in this study
depends on Oct-4 expression.
In addition to Oct-4 expression, we found that SSEA-
4 was consistently expressed in TSCs at low (< 2) and
high passages (~12) even after long term culturing. It is
known that SSEA is developmentally regulated during
early embryogenesis and is widely used as a marker to
monitor the differentiation of both mouse and human
embryonic stem cells [26,27]. Therefore, SSEA-4 may be
used as one of TSC markers. Finally, we found that
nucleostemin was highly expressed in rabbit TSCs.
Nucleostemin is only expressed in the nucleoli of stem
cells and cancer cells, but not in those of committed
and terminally differentiated cells [28]. Thus, the high
levels of nucleostemin expression in rabbit TSCs indi-
cate that TSCs were an actively proliferating, self-renew-
ing population of cells in our culture conditions. On the
other hand, the lack of expression of nucleostemin in
tenocytes suggests that tenocytes are terminally differen-
tiated cells without further differentiation potential, as
indicated by our data. Final l y ,a st h i ss t u d ys h o w st h a t
TSCs, but not tenocytes, express Oct-4, SSEA-4, and
nucleostemin, they may be used as markers to detect
these tendon stem cells in situ.
A few comments are also necessary regarding cell cul-
tures used in this study. First, TSCs are most likely a
mixture of stem cells and progenitor cells, which are
heterogeneous in clonogenicity, multi-differentiation
potential, and self-renewal. The evidence for this
include: 1) colony size of both PTSCs and ATSCs varied
greatly (Figure 1); 2) PTSCs and ATSCs did not undergo
complete differentiation into adipocytes, chondrocytes,
and osteocytes when grown in respective induction
media (Figure 2A-H); and 3) not all individual cells were
noted to express stem cell markers, including Oct-4 and
SSEA-4 (Figure 6). Future studies should look into the
properties (e.g. gene expression profiles) of TSCs at the
individual cell level rather than at the population level
as in this study. Second, when tenocytes were exposed
to induction medium for adipogenesis, a small percen-
tage of cells (< 5%) formed lipid drops (Figure 2I, M).
These positively-stained cells were likely those remain-
ing TSCs and/or their committed progenitor cells, as it
is difficult to isolate pure tenocytes from TSCs using the
separation procedures used in this study.
Tendons are commonly considered to contain only
tenocytes or tendon fibroblasts [18,20,29]. While it was
suggested that there might be a special cell population
within tendons that possesses multiple differentiation
potential [30], the existence of stem cells in human and
mouse tendons was not definitively shown until a recent
study [9]. Our finding that rabbit patellar and Achilles
tendons contain stem cells is consistent with this study.
However, our finding that tenocytes do not have multi-
differentiation potential is inconsistent with an earlier
study, which showed that so called tendon-derived fibro-
blasts can differentiate into adipocytes, chondrocytes,
and osteocytes [10]. Different tissue culture techniques
may account for this discrepancy. Specifically, we used a
tissue digestion method to isolate tendon cells directly
from tendon tissues. Once tendon cells in culture
attached to culture plates, we separated colony-forming
cells, which were TSCs, from those cells that spread out,
Figure 7 The population doubling time (PDT) of TSCs and
tenocytes. Patellar TSCs (PTSCs), Achilles TSCs (ATSCs) at passage 2
proliferated faster than their counterparts: patellar tenocytes (PTs),
and Achilles tenocytes (ATs).
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Page 9 of 11which were considered to be tenocytes. In the study by
de Mos et al., tendon explant cultures were used in
which cells that migrated out from tendon samples were
collected and sub-cultured. Therefore, we suspect that
such cultures contained a mixed population of cells
including tenocytes and TSCs or their progeny cells.
Consequently, those cells that were shown to differenti-
ate into non-tenocytes could actually be TSCs.
While this study shows that TSCs from both patellar
and Achilles tendons exhibit similar patterns in directed
differentiation and gene expression, they display marked
differences in colony formation and cell proliferation
rate. In particular, PTSCs formed more and larger colo-
nies (Figure 1A) and proliferated more rapidly than
ATSCs (Figure 7). The reasons for these differences are
not clear but may reflect inherent differences between
the two tendons in vivo. The patellar tendon is similar
to a ligament as it connects the patella and tibia, and
the structure and composition of the patellar and
Achilles tendons are different. Our findings of biological
differences between patellar and Achilles TSCs support
the notion that characteristics of adult stem cells such
as TSCs are tissue origin-dependent [31]. Furthermore,
the differential proliferative properties of TSCs found in
patellar and Achilles tendons may reflect differences in
their function and regenerative potential in vivo.
Conclusions
This study showed that TSCs differ from tenocytes in
morphology in culture, proliferative potential, and
expression of stem cell markers (Oct-4, SSEA-4, and
nucleostemin). Moreover, unlike tenocytes, TSCs were
shown to possess multi-differentiation potential. Future
research should determine whether TSCs can be used
for more effective repair or possibly for regeneration of
tendinopathic tendons. In addition, considering that ten-
dons are constantly subjected to mechanical loading,
future studies should look into the mechanobiology of
TSCs and the interactions of TSCs with tenocytes, so
that tendon physiology and pathology (e.g. tendinopa-
thy) can be better understood.
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